Evidence map›Paper›PMID 39344511›Full record

ArticleBioscience reports2024

Favourable HDL composition in endurance athletes is not associated with changes in HDL in vitro antioxidant and endothelial anti-inflammatory function.

Jack David Beazer, Anne Sillars, Sally Beck, Christina Christoffersen, Maria J Ferraz, Monique T Mulder, Delyth Graham, Helen Karlsson, Stefan Ljunggren, Jason Gill and 1 more

Abstract read
In one paragraph

Article in Bioscience reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jack David BeazerSchool of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom.ORCID 0000-0001-6978-3072
Anne SillarsSchool of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom.
Sally BeckSchool of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom.
Christina ChristoffersenDepartment of Clinical Biochemistry, Section 3-01-3, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark and Institute of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3A, 2200 Copenhagen, Denmark.
Maria J FerrazMedical Biochemistry, Leiden Institute of Chemistry, Leiden University, Gorlaeus Building, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Monique T MulderDivision of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus University Medical Centre, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Delyth GrahamSchool of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom.
Helen KarlssonOccupational and Environmental Medicine Center in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, SE-58183 Linköping, Sweden.
Stefan LjunggrenOccupational and Environmental Medicine Center in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, SE-58183 Linköping, Sweden.
Jason GillSchool of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom.
Dilys J FreemanSchool of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom.

Funding

British Heart Foundation (BHF) FS/18/58/34179Diabetes UK (DIABETES UK LIMITED) 15/0005182NHS Great Glasgow & Clyde GN23ME032
6 · The paper itself

Abstract

Given the failure of high-density lipoprotein (HDL) raising therapies to reduce cardiovascular disease risk, attention has turned towards HDL composition and vascular protective functions. In individuals with insulin resistance, exercise interventions recover HDL function. However, the effect of exercise on HDL in otherwise healthy individuals is unknown. This cross-sectional study aimed to measure HDL composition and antioxidant/endothelial anti-inflammatory function in insulin sensitive endurance athlete and healthy control men. HDL was isolated using density gradient ultracentrifugation. HDL composition was measured using microplate assays for apolipoprotein A-I, total cholesterol content and apolipoprotein M. HDL protein composition was measured using nano-liquid chromatography tandem mass spectrometry. HDL subclass distribution was measured by native gel electrophoresis. HDL in vitro antioxidant function was measured by paraoxonase-1 activity assay and anti-inflammatory function assessed in endothelial cells. Compared with controls, endurance athlete HDL had higher apolipoprotein A-1 (1.65 ± 0.62 mg/ml vs 1.21 ± 0.34 mg/ml, P=0.028) and higher total cholesterol content (2.09 ± 0.44 mmol/L vs 1.54 ± 0.33 mmol/L, P<0.001). Proteomics revealed higher apolipoprotein A-II, A-IV and D and transthyretin in endurance athlete HDL versus controls. There was no difference observed in in vitro HDL antioxidant or anti-inflammatory functions between controls and endurance athletes. Despite a more favourable composition, endurance athlete HDL did not have higher in vitro antioxidant or anti-inflammatory function. It is possible that HDL has a ceiling of function, i.e. that healthy HDL function cannot be enhanced by endurance exercise.

Indexed as

AntioxidantsAthletesLipoproteins, HDLAdultApolipoprotein A-IAryldialkylphosphataseCase-Control StudiesCross-Sectional StudiesEndothelial CellsHumansMalePhysical EnduranceAntioxidantsApolipoprotein A-IAryldialkylphosphataseLipoproteins, HDLPON1 protein, humanendothelial functionexercisehigh-density lipoproteininsulin resistance

Identifiers

PMID39344511
PMCPMC11499383

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.